Send to

Choose Destination
Clin Oncol. 1983 Mar;9(1):31-4.

Primary treatment of breast cancer in elderly women with Tamoxifen.


One hundred and sixty-one female patients, over the age of 70, with breast cancer were treated by Tamoxifen alone in a pilot phase II study. 61% showed objective regression of the disease and in 27% there was complete remission. The treatment was well tolerated and the survival rate compared favourably to that following conventional methods of treatment. An accurate assessment of the method awaits a randomized clinical trial.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center